Skip to main content
Top
Published in: Surgical Endoscopy 9/2020

01-09-2020 | Bariatric Surgery | 2019 SAGES Oral

Preoperative anticoagulation in patients undergoing bariatric surgery is associated with worse outcomes

Authors: Maria S. Altieri, Jie Yang, Chencan Zhu, L. Konstantinos Spaniolas, Mark A. Talamini, Aurora D. Pryor

Published in: Surgical Endoscopy | Issue 9/2020

Login to get access

Abstract

Introduction

Management of patients on chronic anticoagulation (AC) in bariatric surgery may present a challenge, as there is a delicate balance between risks of bleeding and thrombotic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). The purpose of this study was to evaluate and compare rates of bleeding, thrombotic events, and outcomes of patients on preoperative AC during bariatric surgery.

Methods

The MBSAQIP data sets for 2015 and 2016 was used to identify all patients undergoing adjustable gastric banding (AGB), sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB). Clinical outcomes included length of stay, 30-day readmission, 30-day reoperations and interventions, perioperative and 30-day death events, need for transfusion, PE, and DVT. Following univariate analysis, multivariable logistic regression models and generalized linear regression model for a negative binomial distributed count outcomes were used after adjusting for surgery type and other factors related to each outcome.

Results

There were 269,243 records extracted, as there were 6541 (2.43%) patients on preoperative AC. Rates of transfusion, DVT, and PE were 0.67%, 0.18%, and 0.11%. Following multivariable logistic regression, patients with preoperative AC had higher risks of bleeding and DVT (OR 2.7, 95% CI 2.3–3.3, p-value < 0.0001 and OR 2.8, 95% CI 1.9–4, p-value < 0.0001, respectively). In addition, patients with pre-op AC had a higher risk of 30-day readmission (OR 2.1, 95% CI 1.9–2.3, p < 0.0001)/reoperation (OR 1.5, 95% CI 1.2–1.7, p < 0.0001)/reintervention (OR 2.1, 95% CI 1.8–2.4, p < 0.0001), mortality (OR 2.9, 95% CI 2.04–4.069, p < 0.0001), and longer LOS (ratio 1.2, 95% CI 1.199–1.241, p < 0.0001).

Conclusion

Patients with preoperative AC had worse postoperative outcomes. Bariatric surgeons should be aware of the increased morbidity and mortality, and care must be taken to improve outcomes through close attention to postoperative AC protocols in this group of patients.
Literature
1.
go back to reference Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315(21):2284–2291CrossRef Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315(21):2284–2291CrossRef
3.
go back to reference Buchwald H for the Consensus Conference Panel (2005) Consensus conference statement: bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 1:371–381CrossRef Buchwald H for the Consensus Conference Panel (2005) Consensus conference statement: bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 1:371–381CrossRef
4.
go back to reference Bechtel P, Boorse R, Rovito P et al (2013) Warfarin users prone to coagulopathy in first 30 days after hospital discharge from gastric bypass. Obes Surg 23(10):1515–1519CrossRef Bechtel P, Boorse R, Rovito P et al (2013) Warfarin users prone to coagulopathy in first 30 days after hospital discharge from gastric bypass. Obes Surg 23(10):1515–1519CrossRef
5.
go back to reference Iqbal CW, Cima RR, Pemberton JH (2011) Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations. J Gastrointest Surg 15(11):2016–2022CrossRef Iqbal CW, Cima RR, Pemberton JH (2011) Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations. J Gastrointest Surg 15(11):2016–2022CrossRef
6.
go back to reference Yoshida T, Kitano S, Matsumoto T et al (1998) Laparoscopic cholecystectomy in patients undergoing anticoagulant therapy. Surg Today 28(3):308–312CrossRef Yoshida T, Kitano S, Matsumoto T et al (1998) Laparoscopic cholecystectomy in patients undergoing anticoagulant therapy. Surg Today 28(3):308–312CrossRef
7.
go back to reference Spyropoulos AC, Al-Badri A, Sherwood MW et al (2016) Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost 14(5):875–885CrossRef Spyropoulos AC, Al-Badri A, Sherwood MW et al (2016) Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost 14(5):875–885CrossRef
8.
go back to reference McLemore EC, Harold KL, Cha SS et al (2006) The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg 192(6):860–864CrossRef McLemore EC, Harold KL, Cha SS et al (2006) The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg 192(6):860–864CrossRef
9.
go back to reference Ercan M, Bostanci EB, Ozer I et al (2010) Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy. Langenbecks Arch Surg 395(3):247–253CrossRef Ercan M, Bostanci EB, Ozer I et al (2010) Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy. Langenbecks Arch Surg 395(3):247–253CrossRef
10.
go back to reference Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379CrossRef Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379CrossRef
11.
go back to reference Altieri MS, Yang J, Hajagos J et al (2018) Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures. Surg Endosc 32(12):4805–4812CrossRef Altieri MS, Yang J, Hajagos J et al (2018) Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures. Surg Endosc 32(12):4805–4812CrossRef
12.
go back to reference Kearon C, Hirsh J (1997) Managing oral anticoagulation before and after elective surgery. N Engl J Med 336:1506–1511CrossRef Kearon C, Hirsh J (1997) Managing oral anticoagulation before and after elective surgery. N Engl J Med 336:1506–1511CrossRef
13.
go back to reference Hewitt RL, Chun KL, Flint LM (1999) Current clinical concepts in perioperative anticoagulation. Am Surg 65:270–273PubMed Hewitt RL, Chun KL, Flint LM (1999) Current clinical concepts in perioperative anticoagulation. Am Surg 65:270–273PubMed
14.
go back to reference Sharma G, Hanipah ZN, Aminian A et al (2018) Bariatric surgery in patients on chronic anticoagulation therapy. Obes Surg 28(8):2225–2232CrossRef Sharma G, Hanipah ZN, Aminian A et al (2018) Bariatric surgery in patients on chronic anticoagulation therapy. Obes Surg 28(8):2225–2232CrossRef
15.
go back to reference Mourelo R, Kaidar-Person O, Fajnwalks P et al (2008) Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy. Obes Surg 18:167–170CrossRef Mourelo R, Kaidar-Person O, Fajnwalks P et al (2008) Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy. Obes Surg 18:167–170CrossRef
16.
go back to reference Schullo-Feulner AM, Stoeckler Z, Brouwn GA et al (2014) Warfarin dosing after bariatric surgery: a retrospective study of 10 patients previously stable on chronic warfarin therapy. Clin Obes 4(2):108–115CrossRef Schullo-Feulner AM, Stoeckler Z, Brouwn GA et al (2014) Warfarin dosing after bariatric surgery: a retrospective study of 10 patients previously stable on chronic warfarin therapy. Clin Obes 4(2):108–115CrossRef
17.
go back to reference Gerin O, Rebibo L, Dhahri A et al (2015) The safety of laparoscopic sleeve gastrectomy in patients receiving chronic anticoagulation therapy: a case-matched study. Obes Surg 25(9):1686–1692CrossRef Gerin O, Rebibo L, Dhahri A et al (2015) The safety of laparoscopic sleeve gastrectomy in patients receiving chronic anticoagulation therapy: a case-matched study. Obes Surg 25(9):1686–1692CrossRef
Metadata
Title
Preoperative anticoagulation in patients undergoing bariatric surgery is associated with worse outcomes
Authors
Maria S. Altieri
Jie Yang
Chencan Zhu
L. Konstantinos Spaniolas
Mark A. Talamini
Aurora D. Pryor
Publication date
01-09-2020
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 9/2020
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07191-1

Other articles of this Issue 9/2020

Surgical Endoscopy 9/2020 Go to the issue